A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease

Abdullah Kutlar, Kenneth Ataga, Marvin Reid, Elliott P. Vichinsky, Lynne Neumayr, Loray Blair-Britt, Richard Labotka, Jonathan Glass, Jeffrey R. Keefer, William A. Wargin, Ronald Berenson, Susan P. Perrine

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 1/2 trial of HQK-1001, an oral fetal globin inducer, in sickle cell disease'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases